AVANADE
Avanade , the leading digital innovator on the Microsoft ecosystem, today announced the launch of its business in the United Arab Emirates (UAE), with offices in Dubai and Abu Dhabi. Adriano Neves, Avanade’s Sales, Industry and Client Relationships Lead in Brazil, has been appointed to lead the company’s newest entity and will relocate from São Paulo to Dubai.
Established by Accenture and Microsoft in 2000, Avanade today has 49,000 professionals globally focused on the Microsoft ecosystem providing technology and consulting expertise to help clients from across industries including financial services, oil and gas, and citizen services. Avanade’s presence in the United Arab Emirates represents the 26th country location in the company’s expanding global footprint.
Leveraging its global delivery network, technical depth and Microsoft-focused capabilities, Avanade will work with Accenture to jointly help clients in the UAE create exceptional experiences, build operational resilience and reimagine new business models. In the recently published “IDC MarketScape: Worldwide Microsoft Implementation Services 2021 Vendor Assessment ,” Accenture and Avanade have been jointly recognized as a leader based on current capabilities and future strategies. Together, Accenture and Avanade have been named Microsoft Global Alliance SI Partner of the Year 16 times , more than any other partner.
Adriano Neves, Avanade’s United Arab Emirates regional lead, said: “As organizations renew for the future, we want to make a positive impact in the region by helping our clients solve complex business problems that are unique to their industries and realize their business goals faster on the Microsoft platform.”
Nadya Abdulla Kamali, Accenture’s country managing director for the UAE, said: “We are thrilled to welcome Avanade to the United Arab Emirates. With our combined service capabilities, global scale and joint solution development on the Microsoft platform, we look forward to helping our clients drive an end-to-end digital transformation of their businesses.”
Sayed Hashish, General Manager, Microsoft UAE added: “Our partnership with Accenture through Avanade has grown tremendously, and the launch of Avanade in the United Arab Emirates marks another milestone for our successful collaboration. Together with Avanade and Accenture, we will continue to empower every person and organization in the UAE to achieve more.”
To fuel the company’s ambitious growth, Avanade is recruiting digital, IT and consulting specialists who have a passion for Microsoft platform technologies. Interested individuals are encouraged to apply for open roles here: https://www.avanade.com/en/career
About Adriano Neves, United Arab Emirates Regional Lead, Avanade
Based in Dubai, Adriano Neves leads a team of digital professionals focused on powering the Accenture Microsoft Business Group and helping enterprises realize business outcomes on the Microsoft platform. Prior to his current role, Adriano was responsible for Avanade’s Sales, Industry and Client Relationships in Brazil focused on delivering exceptional experiences and making a genuine human impact for clients. As one of Avanade’s first employees in Brazil, Adriano played a pivotal role in partnering with Accenture and Microsoft to not only establish Avanade’s business and market presence in the region, but to build the most relevant Microsoft partner in the region. Before he joined Avanade, Adriano spent nearly 10 years in a variety of leadership roles at Microsoft Brazil. In his spare time, Adriano volunteers as a business advisor to startups.
About Accenture
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 569,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com .
About Avanade
Avanade is the leading provider of innovative digital and cloud services, business solutions and design-led experiences on the Microsoft ecosystem. Our professionals bring bold, fresh thinking combined with technology, business and industry expertise to help make a genuine human impact for our clients, their customers and their employees. We are the power behind the Accenture Microsoft Business Group, helping companies to engage customers, empower employees, optimize operations and transform products, leveraging the Microsoft platform. Avanade has 49,000 professionals in 26 countries, bringing clients our best thinking through a collaborative culture that honors diversity and reflects the communities in which we operate. Majority owned by Accenture, Avanade was founded in 2000 by Accenture LLP and Microsoft Corporation. Learn more at www.avanade.com .
About Microsoft
Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.
*Source : AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005412/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release
Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom